Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
If youre looking for a more tailored approach to weight losswith medical guidance and ongoing support this limited-time discount could be worth considering
GLP-1 receptor agonists have become a central focus in metabolic health care, especially for individuals managing obesity or Type 2 diabetes
LifeVantage issued upside FQ2 2025 revenue guidance of $ 67.5 million versus $51.45 million consensus estimates
NUTRITIONAL SCORE: 60 36
Here, well cover the main points to consider when going off GLP-1 therapy and what to expect
US$ 25.12
US$ 25.11
US$ 26.75
US$ 25.51
US$ 25.09
US$ 25.51
US$ 20.16
US$ 22.51
US$ 26.48
US$ 23.57
US$ 22.75
US$ 23.45
US$ 21.12
US$ 28.32
